(ANAB) – Analyst PT Change
-
AnaptysBio (ANAB) PT Lowered to $28 at JPMorgan
-
Anaptysbio (ANAB) a key player in next wave of immune cell modulatory therapies - Stifel
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ANAB Stock Lookup